Paymon Farazi - 03 Aug 2022 Form 4 Insider Report for Signify Health, Inc.

Role: Chief Product Officer
Signature: /s/ Adam McAnaney as Attorney-in-Fact for Paymon Farazi
Issuer symbol: N/A
Transactions as of: 03 Aug 2022
Net transactions value: $0
Form type: 4
Filing time: 05 Aug 2022, 16:24:53 UTC
Previous filing: 18 Jul 2022
Next filing: 04 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SGFY	Class A Common Stock	Award	$0	+47,375		$0.000000	47,375	03 Aug 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SGFY	Employee Stock Option (Right to Buy)	Award	$0	+142,125		$0.000000	142,125	03 Aug 2022	Class A Common Stock	142,125	$18.47	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units on August 3, 2022 that will vest in equal annual installments on each of the first four anniversaries of the grant date.
F2	These options vest in equal annual installments on each of the first four anniversaries of the August 3, 2022 grant date.